{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:16:53Z","timestamp":1778051813714,"version":"3.51.4"},"reference-count":34,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"Innovative Medicines Initiative Joint Undertaking","award":["115156"],"award-info":[{"award-number":["115156"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"abstract":"<jats:p>In vivo studies have investigated the role of \u03b2-cell dysfunction in type 2 diabetes (T2D), whereas in vitro research on islets has elucidated key mechanisms that control the insulin secretion rate. However, the relevance of the cellular mechanisms identified in vitro (i.e., the triggering and amplifying pathways) has not been established in vivo. Furthermore, the mechanisms underpinning \u03b2-cell dysfunction in T2D remain undetermined. We propose a unifying explanation of several characteristic features of insulin secretion both in vitro and in vivo by using a mathematical model. The model describes the triggering and amplifying pathways and reproduces a variety of in vitro and in vivo tests in subjects with and without T2D, identifies the mechanisms modulating first-phase insulin secretion rate in response to basal hyperglycemia or insulin resistance, and shows that \u03b2-cell dysfunction in T2D can be explained by an impaired amplifying pathway with no need to postulate defects in intracellular calcium handling.<\/jats:p>","DOI":"10.2337\/db17-1039","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T01:35:12Z","timestamp":1513042512000},"page":"496-506","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":23,"title":["Defective Amplifying Pathway of \u03b2-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence"],"prefix":"10.2337","volume":"67","author":[{"given":"Eleonora","family":"Grespan","sequence":"first","affiliation":[{"name":"Institute of Neuroscience, National Research Council, Padua, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6449-0596","authenticated-orcid":false,"given":"Toni","family":"Giorgino","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, National Research Council, Padua, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-9324","authenticated-orcid":false,"given":"Silva","family":"Arslanian","sequence":"additional","affiliation":[{"name":"Division of Weight Management, Children\u2019s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"},{"name":"Division of Pediatric Endocrinology, Diabetes and Metabolism, Children\u2019s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-1584","authenticated-orcid":false,"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council, Pisa, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1436-5591","authenticated-orcid":false,"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, National Research Council, Padua, Italy"}]}],"member":"1167","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"2022031303484040200_B1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(73)90599-0","article-title":"Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects","volume":"1","author":"Cerasi","year":"1973","journal-title":"Lancet"},{"key":"2022031303484040200_B2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-003-1153-1","article-title":"Insulin granule dynamics in pancreatic beta cells","volume":"46","author":"Rorsman","year":"2003","journal-title":"Diabetologia"},{"key":"2022031303484040200_B3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00125-009-1314-y","article-title":"Regulation of insulin secretion: a matter of phase control and amplitude modulation","volume":"52","author":"Henquin","year":"2009","journal-title":"Diabetologia"},{"key":"2022031303484040200_B4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-physiol-030212-183754","article-title":"Regulation of insulin secretion in human pancreatic islets","volume":"75","author":"Rorsman","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"2022031303484040200_B5","first-page":"583","article-title":"The pilot gland approach to the study of insulin secretory dynamics","volume":"27","author":"Bergman","year":"1971","journal-title":"Recent Prog Horm Res"},{"key":"2022031303484040200_B6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI107011","article-title":"A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling","volume":"51","author":"Grodsky","year":"1972","journal-title":"J Clin Invest"},{"key":"2022031303484040200_B7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2362.1974.tb02345.x","article-title":"A mathematical model for the glucose induced insulin release in man","volume":"4","author":"Cerasi","year":"1974","journal-title":"Eur J Clin Invest"},{"key":"2022031303484040200_B8","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1529\/biophysj.107.124990","article-title":"Identifying the targets of the amplifying pathway for insulin secretion in pancreatic \u03b2-cells by kinetic modeling of granule exocytosis","volume":"95","author":"Chen","year":"2008","journal-title":"Biophys J"},{"key":"2022031303484040200_B9","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0901202106","article-title":"Newcomer insulin secretory granules as a highly calcium-sensitive pool","volume":"106","author":"Pedersen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031303484040200_B10","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.2337\/diabetes.51.2007.S60","article-title":"Signals and pools underlying biphasic insulin secretion","volume":"51","author":"Henquin","year":"2002","journal-title":"Diabetes"},{"key":"2022031303484040200_B11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diabetes.55.02.06.db05-1051","article-title":"In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in \u03b2-cells","volume":"55","author":"Henquin","year":"2006","journal-title":"Diabetes"},{"key":"2022031303484040200_B12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2337\/diabetes.50.3.540","article-title":"Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response","volume":"50","author":"Jonkers","year":"2001","journal-title":"Diabetes"},{"key":"2022031303484040200_B13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"2022031303484040200_B14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s001250051027","article-title":"Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis","volume":"41","author":"Mari","year":"1998","journal-title":"Diabetologia"},{"key":"2022031303484040200_B15","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.2337\/db13-1951","article-title":"\u03b2-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes","volume":"63","author":"Michaliszyn","year":"2014","journal-title":"Diabetes"},{"key":"2022031303484040200_B16","doi-asserted-by":"crossref","first-page":"E919","DOI":"10.1152\/ajpendo.00428.2015","article-title":"Impact of a mild decrease in fasting plasma glucose on \u03b2-cell function in healthy subjects and patients with type 2 diabetes","volume":"310","author":"Seghieri","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303484040200_B17","doi-asserted-by":"crossref","first-page":"E1144","DOI":"10.1152\/ajpendo.00571.2005","article-title":"Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance","volume":"291","author":"Muscelli","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303484040200_B18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/db07-1315","article-title":"Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients","volume":"57","author":"Muscelli","year":"2008","journal-title":"Diabetes"},{"key":"2022031303484040200_B19","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2337\/diabetes.51.2007.S130","article-title":"Effect of acute hyperglycemia on insulin secretion in humans","volume":"51","author":"Toschi","year":"2002","journal-title":"Diabetes"},{"key":"2022031303484040200_B20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00125-009-1647-6","article-title":"Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance","volume":"53","author":"Mari","year":"2010","journal-title":"Diabetologia"},{"key":"2022031303484040200_B21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1464-5491.2008.02441.x","article-title":"Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes","volume":"25","author":"Mari","year":"2008","journal-title":"Diabet Med"},{"key":"2022031303484040200_B22","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/diabetes.49.11.1751","article-title":"Triggering and amplifying pathways of regulation of insulin secretion by glucose","volume":"49","author":"Henquin","year":"2000","journal-title":"Diabetes"},{"key":"2022031303484040200_B23","doi-asserted-by":"crossref","first-page":"C697","DOI":"10.1152\/ajpcell.00329.2010","article-title":"Metabolic amplification of insulin secretion by glucose is independent of \u03b2-cell microtubules","volume":"300","author":"Mourad","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"2022031303484040200_B24","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1172\/JCI82498","article-title":"Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional \u03b2 cells","volume":"125","author":"Ferdaoussi","year":"2015","journal-title":"J Clin Invest"},{"key":"2022031303484040200_B25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2013.05.018","article-title":"Metabolic signaling in fuel-induced insulin secretion","volume":"18","author":"Prentki","year":"2013","journal-title":"Cell Metab"},{"key":"2022031303484040200_B26","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/tra.12286","article-title":"A spatial model of insulin-granule dynamics in pancreatic \u03b2-cells","volume":"16","author":"Dehghany","year":"2015","journal-title":"Traffic"},{"key":"2022031303484040200_B27","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.2337\/diabetes.53.12.3179","article-title":"Stimulation of insulin release by glucose is associated with an increase in the number of docked granules in the \u03b2-cells of rat pancreatic islets","volume":"53","author":"Straub","year":"2004","journal-title":"Diabetes"},{"key":"2022031303484040200_B28","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1152\/ajpendo.00251.2015","article-title":"Dynamics of glucose-induced insulin secretion in normal human islets","volume":"309","author":"Henquin","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303484040200_B29","first-page":"3","article-title":"Differential actions of glucose on insulin release: re-evaluation of a mathematical model in carbohydrate metabolism","volume-title":"Quantitative Physiology and Mathematical Modelling","author":"Cerasi","year":"1981"},{"key":"2022031303484040200_B30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/BF00400466","article-title":"Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man","volume":"37","author":"Del Prato","year":"1994","journal-title":"Diabetologia"},{"key":"2022031303484040200_B31","doi-asserted-by":"crossref","first-page":"e73154","DOI":"10.1371\/journal.pone.0073154","article-title":"Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes","volume":"8","author":"Mari","year":"2013","journal-title":"PLoS One"},{"key":"2022031303484040200_B32","first-page":"E572","article-title":"Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function","volume":"270","author":"Byrne","year":"1996","journal-title":"Am J Physiol"},{"key":"2022031303484040200_B33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ceca.2014.09.001","article-title":"Calcium signaling in pancreatic \u03b2-cells in health and in type 2 diabetes","volume":"56","author":"Gilon","year":"2014","journal-title":"Cell Calcium"},{"key":"2022031303484040200_B34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/dom.12887","article-title":"Pharmacological approach to understanding the control of insulin secretion in human islets","volume":"19","author":"Henquin","year":"2017","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db17-1039","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/67\/3\/496\/537668\/db171039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/67\/3\/496\/537668\/db171039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:34:37Z","timestamp":1667406877000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/67\/3\/496\/40000\/Defective-Amplifying-Pathway-of-Cell-Secretory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,12,11]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db17-1039","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}